MedAI Verdict
Billing & coding

AI Medical Billing

TE

Tennr

by Tennr  ·  founded 2021  ·  US

Last verified

Agentic referral intake, eligibility checks and prior authorization submission for DME, infusion and specialty groups.

Visit Tennr (opens in new tab)Read our methodology

At a glance

Pricing
No public price. CTA is "book a demo".
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
2021
HQ
US
On this page

Independent score  ·  By our public rubric

21/100Niche fit

Not rated: too little independent evidence yet.

How it’s computed →
  • Regulatory & Compliance
    0/10

    No public HIPAA/SOC2/BAA attestation

  • Clinical Integration
    0/31.4

    No EHR integrations listed

  • Evidence Strength
    0/10

    No peer-reviewed coverage

  • Vendor & Market
    12.6/18

    Mid-tier funding and adoption

  • Sentiment & Transparency
    3.3/6.5

    Pricing on request, no public amounts

▸ Show all 11 dimensions

Regulatory & Compliance

  • HIPAA / SOC2 / BAA0/10

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/18

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/8

    None of the top-3 EHRs covered

  • Bidirectional write-back0/5

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/7

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/3

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal8/12

    Mid-tier funding and adoption

  • Years in market4/6

    Founded 2021 (5 years)

Sentiment & Transparency

  • Pricing transparency3/7

    Pricing on request, no public amounts

Scored November 2, 2026 · Public scoring method v1.2.0

Agentic referral intake, eligibility checks and prior authorization submission for DME, infusion and specialty groups.

No public price. CTA is "book a demo".

Evidence record

Verification
  • Score computed November 2, 2026, method 1.2.0
  • Review written November 2, 2026
Cite this record

MedAI Verdict, Tennr record, https://medaiverdict.com/tools/tennr, version November 2, 2026

Change history
View every change to this record

Bottom line

Tennr calls itself "an agentic patient orchestration platform built for policy-grade decisioning and patient flow at scale," and its tagline points at DME, infusion and specialty groups. Per the homepage, referrals arrive by fax, portal or internal order, and Tennr classifies them, extracts the data and checks eligibility and benefits. Groups that take referrals this way are the intended users, and its one case study comes from a DME company.

How Tennr describes the workflow

The homepage says Tennr "collects and completes patient documentation using every channel your staff does," then uses proprietary models, branded RaeLM on the about page, to compare it with payer criteria the vendor calls "always-up-to-date." Per the homepage, it can "check eligibility, investigate benefits over the phone, and submit prior authorizations," makes inbound and outbound AI phone calls in several languages, and gives referrers a visibility portal. The homepage says charts and orders are updated wherever they live and names no EHR.

Home Medix, the named case study

Home Medix, a DME company, reports in a Tennr-written case study that it takes referrals 75% faster and handles 4X the volume. Intake fell from 25 minutes to under 5, and the team went from 5 full-time staff to 2 Tennr users over 6 months. Its CEO, Josh Arabian, says: "Instead of spending half an hour on each entry, we're now in and out in less than 5 minutes." The story also mentions benefits verification and "billing qualification review" products.

The about page claims the platform "processes over 10m documents per month" and that Tennr "processed over 10M patients in 2025." The homepage adds "millions of care pathways each month." Neither page gives a customer count.

PubMed lists 0 results for "Tennr."

Founders and funding, as reported

IVP led a US$101M Series C in June 2025 at a post-money valuation of about US$605M, according to The SaaS News. A US$37M Series B came in October 2024, and totals run from about $159M to $162M depending on the aggregator. Coverage also names a16z, Lightspeed, GV, ICONIQ, Foundation Capital and Frank Slootman among investors, and Axios covered the Andreessen Horowitz backing in March 2024. Aggregator listings credit Trey Holterman (CEO), Tyler Johnson (CTO) and Diego Baugh (CPO) with founding Tennr in 2021, and the about page says the founders met at Stanford working on advanced AI and LLM research.

Security

The Trust Center at trust.tennr.com reports "This Trust Center is unavailable." HIPAA, SOC 2 and HITRUST status appears on neither the homepage nor the about page.

Cost

Tennr has no public price. The route to one is the "book a demo" page.

The verdict

Evidence for Tennr sits in one setting, DME intake at Home Medix, so DME groups are the closest match. The homepage describes no claim coding.

Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

What it costs

All tiers are custom-quoted. The vendor does not publish per-provider list pricing.

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. CTA is "book a demo".

Source: vendor pricing page. Last checked November 2, 2026.

Who builds it

Tennr (Tennr) was founded in 2021 in US, putting it 5 years into market.

Other billing & coding

See the full billing & coding ranking